Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness

Journal of Biomedical Materials Research

Volumn 55, Issue 3, 2001, Pages 350-359

  Boyan, B D ^a,c,d   Lohmann, C H ^a   Sisk, M ^a,b   Liu, Y ^a,b   Sylvia, V L ^b   Cochran, D L ^e   Dean, D D ^b   Schwartz, Z ^a,e  

^a University of Texas Health Science Center at San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d WILFORD HALL MEDICAL CENTER   (United States)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Cyclooxygenase; Differentiation; Local factors; Osteoblasts; Surface roughness; Titanium

Indexed keywords

BIOSYNTHESIS; CELLS; SURFACE ROUGHNESS; TISSUE CULTURE;

OSTEOBLASTS;

ENZYME KINETICS;

ALKALINE PHOSPHATASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; OSTEOCALCIN; PROSTAGLANDIN; PROSTAGLANDIN E2; PROTEIN; RESVERATROL; TITANIUM; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOBLAST; PHENOTYPE; SURFACE PROPERTY;

ALKALINE PHOSPHATASE; BIOCOMPATIBLE MATERIALS; CELL LINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; HUMANS; INDOMETHACIN; ISOENZYMES; MATERIALS TESTING; MEMBRANE PROTEINS; NITROBENZENES; OSTEOBLASTS; OSTEOCALCIN; PHENOTYPE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STILBENES; SULFONAMIDES; SURFACE PROPERTIES; TITANIUM; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035811274     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4636(20010605)55:3<350::AID-JBM1023>3.0.CO;2-M     Document Type: Article

References (59)

1. Cellular regulation of prostaglandin H synthase catalysis
2. Comparative molecular modeling study of the three-dimensional structures of prostaglandin endoperoxide H2 synthase 1 and 2 (COX-1 and COX-2)
3. Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation
4. Shortcourse indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty
5. Mice lacking 5-lipoxygenase have increased cortical bone thickness
6. The effects of nonsteroidal anti-inflammatory drugs on posterior spinal fusions in the rat
7. The effect of indomethacin, aspirin, and ibuprofen on bone ingrowth into a porous-coated implant
8. Effects of indomethacin on biologic fixation of porous-coated titanium implants
9. Surface roughness modulates the local production of growth factors and cytokines by osteoblast-like MG63 cells
10. Response of MG63 osteoblast-like cells to titanium and titanium alloy is dependent on surface roughness and composition
11. 3
12. Inhibition of cyclooxygenase by indomethacin modulates osteoblast response to titanium surface roughness in a time-dependent manner
13. 3
14. Prostaglandins: Mechanisms of action and regulation of production in bone
15. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
16. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
17. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions
18. Selective inhibitors of cyclooxygenase-2. Potential in elderly patients
19. The influence of various titanium surfaces on the interface shear strength between implants and bone
20. Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs
21. Evaluation of an endosseous titanium implant with a sandblasted and acid-etched surface in the canine mandible: Radiographic results
22. Bone response to unloaded and loaded titanium implants with a sandblasted and acid-etched surface: A histometric study in the canine mandible
23. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63)
24. Effect of titanium surface roughness on chondrocyte proliferation, matrix production, and differentiation depends on the state of cell maturation
25. 2 activity and activation of protein kinase A
26. 3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line
27. 3 responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG 63, and MC 3T3) and growth cartilage cells in culture
28. 3 on differentiation of a human osteosarcoma (MG-63)
29. 3 in three osteoblast-like cell lines (MC-3T3-E1, ROS 17/2.8, and MG-63)
30. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
31. Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions
32. Eicosanoid biosynthesis in an advanced deuterostomate invertebrate, the sea squirt (Ciona intestinalis)
33. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells
34. Prostaglandins as mediators of bone cell metabolism
35. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture
36. Measurement of protein using bicinchoninic acid
37. Alkaline phosphatases
38. 2 on costochondral chondrocyte differentiation is mediated by cAMP and protein kinase C
39. 3 on growth plate chondrocytes in a metabolite-specific and cell maturation-dependent manner
40. 2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts
41. 2 in rat bone marrow cultures is mediated via the EP4 receptor subtype
42. 2, cAMP and cAMP-dependent protein kinase isozymes during decidualization of rat endometrial stromal cells in vitro
43. Cox-1, Cox-2, and Cox-3 and the future treatment of chronic inflammatory disease
44. 3 via protein kinase C and indirectly through prostaglandin production in resting zone chondrocytes
45. 2 and phospholipase C in growth zone chondrocytes
46. 3 on growth plate chondrocytes
47. Ligand selectivity of the peroxisome proliferator-activated receptor alpha
48. Fatty acid activation of peroxisome proliferator-activated receptor (PPAR)
49. Lysophosphatidic acid signalling
50. Protein kinase C regulates chondrogenesis of mesenchymes via mitogen-activated protein kinase signaling
51. Regulation of human osteoblast integrin expression by orthopaedic implant materials
52. Eicosanoids. Critical agents in the physiological process and cellular injury
53. Transforming growth factor-beta inhibition of mineralization by neonatal rat osteoblasts in monolayer and collagen gel culture
54. Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts
55. Characterization and autoregulation of latent transforming growth factor β (TGFβ) complexes in osteoblast-like cell lines
56. Prostaglandin-mediated modulation of transforming growth factor-beta
57. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts
58. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2
59. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix